Subcutaneous panniculitis-like T-cell lymphoma: The authors’ experience of diagnosis and treatment


Cite item

Full Text

Abstract

The paper gives the data of clinical, histological, immunohistochemical, and molecular studies and the results of positron emission tomography in 3 cases of subcutaneous panniculitis-like T-cell lymphoma (SPTCL). It shows the high efficiency of a GEM-P regimen in the treatment of patients with SPTCL.

References

  1. Gonzalez CL, Medeiros LJ, Braziiel RM, Jaffe ES. T-cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol. 1991;15(1):17-27. doi: 10.1097/00000478-199101000-00002
  2. Go RS, Wester SM. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature. Cancer. 2004;101(6):1404-1413. doi: 10.1002/cncr.20502
  3. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768-3785. doi: 10.1182/blood-2004-09-3502
  4. Jaffe ES, Gaulard P, Ralfkiaer E et al. Subcutaneous panniculitis-like T-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL et al., eds. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th ed: Lyon: IARC; 2008:294-295.
  5. Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C, Canninga-van Dijk MR, Carlotti A, Geerts ML, Hahtola S, Hummel M, Jeskanen L, Kempf W, Massone C, Ortiz-Romero PL, Paulli M, Petrella T, Ranki A, Peralto JL, Robson A, Senff NJ, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ; EORTC Cutaneous Lymphoma Group. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. 2008;111(2):838-845. doi: 10.1182/blood-2007-04-087288
  6. Parveen Z, Thompson K. Subcutaneous panniculitis-like T-cell lymphoma redefinition of diagnostic criteria in the recent World Health Organization - European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas. Arch Pathol Lab Med. 2009;133(2):303-308. doi: 10.1043/1543-2165-133.2.303
  7. Oschlies I, Simonitsch-Klupp I, Maldyk J, Konovalov D, Abramov D, Myakova N, Lisfeld J, Attarbaschi A, Kontny U, Woessmann W, Klapper W. Subcutaneous panniculitis-like T-cell lymphoma in children - a detailed clinico-pathological description of 11 multifocal cases: high frequence of hemophagocytic syndrom. Br J Dermatol. 2015;172(3):793-797. doi: 10.1111/bjd.13440
  8. Lozzi GP, Massone C, Citarella L, Kerl H, Cerroni L. Rimming of adipocytes by neoplastic lymphocytes: a histopathologic feature not restricted to subcutaneous T-cell lymphoma. Am J Dermatopathol. 2006;28(1):9-12. doi: 10.1097/01.dad.0000187933.87103.03
  9. Kadin ME. Genetic and molecular genetic studies in the diagnosis of T-cell malignancies. Hum Pathol. 2003;34(4):322-329. doi: 10.1053/hupa.2003.94
  10. Kong YY, Dai B, Kong JC, Zhou XY, Lu HF, Shen L, Du X, Shi DR. Subcutaneous panniculitis-like T-cell lymphoma. A clinicopathologic, immunophenotypic, and molecular study of 22 asian cases according to WHO-EORTC classification. Am J Surg Pathol. 2008;32(10):1495-1502. doi: 10.1097/PAS.0b013e31817a9081
  11. van Dongen JJ, Langerak AW, Brüggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, García-Sanz R, van Krieken JH, Droese J, González D, Bastard C, White HE, Spaargaren M, González M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17(12):2257-2317. doi: 10.1038/sj.leu.2403202
  12. Sandberg Y, van Gastel-Mol EJ, Verhaaf B, Lam KH, van Dongen JJ, Langerak AW. BIOMED-2 multiplex immunoglobulin / T-cell receptor polymerase chain reaction protocols can reliably replace southern blot analysis in routine clonality diagnostics. J Mol Diagn. 2005;7(4):495-503. doi: 10.1016/S1525-1578(10)60580-6
  13. Cerroni L, Gatter K, Kerl H. Subcutaneous «panniculitis-like» T-cell lymphoma. In: Skin Lymphoma.The illustrated guide to guide. 3th ed: Wiley-Blackwell Publishing; 2009:87-96.
  14. Lee DW, Yang JH, Lee SM, Won CH, Chang S, Lee MW, Choi JH, Moon KC. Subcutaneous panniculitis-like T-cell lymphoma: A clinical and pathologic study of 14 Korean patients. Ann Dermatol. 2011;23(3):329-337. doi: 10.5021/ad.2011.23.3.329
  15. Kong YY, Dai B, Kong JC, Zhou XY, Lu HF, Shen L, Du X, Shi DR. Subcutaneous panniculitis-like T-cell lymphoma: A clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Am J Surg Pathol. 2008;32(10):1495-1502. doi: 10.1097/PAS.0b013e31817a9081
  16. Rodriguez VR, Joshi A, Peng F, Rabah RM, Stockmann PT, Savaşan S. Positron emission tomography in subcutaneous panniculitis-like T-cell lymphoma. Pediatr Blood Cancer. 2009;52(3): 406-408. doi: 10.1002/pbc.21805
  17. Babb A, Zerizer I, Naresh KN, Macdonald D. Subcutaneous panniculitis-like T-cell lymphoma with extracutaneous dissemination demonstrated on FDG PET/CT. Am J Hematol. 2011;86(4):375-376. doi: 10.1002/ajh.21874
  18. Uematsu T, Kasami M. 3T-MRI, elastography, digital mammography, and FDG-PET CT findings of subcutaneous panniculitis-like T-cell lymphoma (SPTCL) of the breast. Jpn J Radiol. 2012;30(9):766-771. doi: 10.1007/s11604-012-0112-5
  19. Kim JS, Jeong YJ, Sohn MH, Jeong HJ, Lim ST, Kim DW, Kwak JY, Yim CY. Usefulness of F-18 FDG PET/CT in subcutaneous panniculitis-like T cell lymphoma: disease extent and treatment response evaluation. RadiolOncol. 2012;46(4):279-283. doi: 10.2478/v10019-012-0017-z
  20. Mitsuhashi K, Momose M, Masuda A, Tsunemi Y, Motoji T.Positron emission tomography revealed diffuse involvement of the lower legs and occult extracutaneous lesions in subcutaneous panniculitis-like T-cell lymphoma. Clin Nucl Med. 2013;38(3):209-211. doi: 10.1097/RLU.0b013e31827087ca
  21. Lester L, Ewalt M, Warnke R, Kim J. Systemic panniculitis-like T-cell lymphoma with involvement of mesenteric fat and subcutis. J Cutan Pathol. 2015;42(1):46-49. doi: 10.1111/cup.12436
  22. Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O’Doherty MJ, Hustinx R, Biggi A, Cheson BD. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32(27):3048-3058. doi: 10.1200/JCO.2013.53.5229
  23. Tsukamoto Y, Katsunobu Y, Omura Y, Maeda I, Hirai M, Teshima H, Konishi Y, Inoue T, Sato T. Subcutaneous panniculitis-like T-cell lymphoma: successful initial treatment with prednisolone and cyclosporin A. Intern Med. 2006;45(1):21-24. doi: 10.2169/internalmedicine.45.1433
  24. Iqbal N, Raina V. Successful treatment of disseminated subcutaneous panniculitis-like T-cell lymphoma with single agent oral cyclosporine as a first line therapy. Case Rep Dermatol Med. 2014. doi: 10.1155/2014/201836
  25. Quintanilla-Martinez L, Jansen PM, Kinney MC, Swerdlow SH, Willemze R. Non-mycosis fungoides cutaneous T-cell lymphomas: report of the 2011 Society for hematopathology/european association for haematopathology workshop. Am J Clin Pathol. 2013;139(4):491-514. doi: 10.1309/AJCP83AOQTMLOJTM
  26. Ng M, Waters J, Cunningham D, Chau I, Horwich A, Hill M, Norman AR, Wotherspoon A, Catovsky D. Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma. Br J Cancer. 2005;92(8):1352-1357. doi: 10.1038/sj.bjc.6602514
  27. Arkenau HT, Chong G, Cunningham D, Watkins D, Sirohi B, Chau I, Wotherspoon A, Norman A, Horwich A, Matutes E. Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience. Haematologica. 2007;92(2):271-272. doi: 10.3324/haematol.10737
  28. Yim KL, Ashley S. Assessment of gemcitabine, cisplatin and methylprednisolone (GEM-P) combination treatment for non-Hodgkin T cell lymphoma. Med Oncol. 2012;29(5):3535-3539. doi: 10.1007/s12032-012-0309-6
  29. Velez NF, Ishizawar RC, Dellaripa PF, Saavedra AP, Laga AC, Murphy GF, Fisher DC, Kupper TS, Vleugels RA. Full facial edema: a novel presentation of subcutaneous panniculitis-like T-cell lymphoma. J Clin Oncol. 2012;30(25):e233-236. doi: 10.1200/JCO.2011.40.7684

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies